Exploring the Potential of Rapamycin: Clinical Trial
Rapamycin, also known as sirolimus, is a macrolide compound that was first discovered in the soil of Easter Island (Rapa Nui) in the 1970s. Initially identified for its antifungal properties, rapamycin has since garnered significant attention for its immunosuppressive and anti-proliferative effects. It is primarily used in clinical settings to prevent organ transplant rejection and […]
Exploring the Potential of Rapamycin: Clinical Trial Read More »










